Investors Purchase High Volume of BuzzFeed Call Options (NASDAQ:BZFD)
by Doug Wharley · The Cerbat GemBuzzFeed, Inc. (NASDAQ:BZFD – Get Free Report) was the target of some unusual options trading on Friday. Investors purchased 2,640 call options on the stock. This represents an increase of 575% compared to the typical volume of 391 call options.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of BZFD. Shay Capital LLC lifted its position in BuzzFeed by 115.1% during the 3rd quarter. Shay Capital LLC now owns 179,207 shares of the company’s stock worth $305,000 after acquiring an additional 95,879 shares during the last quarter. Squarepoint Ops LLC increased its stake in shares of BuzzFeed by 259.0% in the third quarter. Squarepoint Ops LLC now owns 42,698 shares of the company’s stock worth $73,000 after purchasing an additional 30,803 shares during the period. Blair William & Co. IL acquired a new position in shares of BuzzFeed during the 3rd quarter worth about $29,000. Vanguard Group Inc. lifted its position in shares of BuzzFeed by 8.8% during the 3rd quarter. Vanguard Group Inc. now owns 976,888 shares of the company’s stock worth $1,661,000 after purchasing an additional 79,263 shares during the last quarter. Finally, Founders Financial Securities LLC boosted its stake in BuzzFeed by 29.6% during the 3rd quarter. Founders Financial Securities LLC now owns 61,545 shares of the company’s stock valued at $105,000 after purchasing an additional 14,045 shares during the period. Institutional investors own 37.64% of the company’s stock.
BuzzFeed Stock Performance
BuzzFeed stock remained flat at $1.19 during trading hours on Friday. The company’s stock had a trading volume of 914,708 shares, compared to its average volume of 342,010. The firm has a market capitalization of $44.28 million, a price-to-earnings ratio of -119,000.00 and a beta of 3.43. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 0.32. The firm has a 50 day moving average price of $1.32 and a 200-day moving average price of $1.80. BuzzFeed has a 52-week low of $0.84 and a 52-week high of $3.60.
BuzzFeed (NASDAQ:BZFD – Get Free Report) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.14). BuzzFeed had a net margin of 0.06% and a negative return on equity of 38.20%. The firm had revenue of $46.32 million during the quarter, compared to the consensus estimate of $54.65 million.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on BZFD shares. Wall Street Zen lowered shares of BuzzFeed from a “hold” rating to a “sell” rating in a research report on Saturday, November 22nd. Craig Hallum lowered shares of BuzzFeed from a “buy” rating to a “hold” rating and set a $1.00 price target on the stock. in a research note on Friday, November 21st. Finally, Weiss Ratings restated a “sell (d)” rating on shares of BuzzFeed in a report on Monday. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $1.00.
View Our Latest Analysis on BuzzFeed
About BuzzFeed
BuzzFeed, Inc, a digital media company, distributes content across owned and operated, as well as third-party platforms. The company offers BuzzFeed, a go-to authority for entertainment, pop culture, and Internet with articles, lists, quizzes, videos, and original series; BuzzFeed News, a pocket friendly newsroom; Tasty, a platform for food content; HuffPost, media platform for news, politics, opinion, entertainment, features, and lifestyle content.
Featured Stories
- Five stocks we like better than BuzzFeed
- Buy P&G Now, Before It Sets A New All-Time High
- Qualcomm Just Got Called an AI Loser—So Why Is It Rallying?
- Earnings Per Share Calculator: How to Calculate EPS
- 2 Small-Cap Biotechs That Could Reward Patient Investors
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Santa Claus May Be Coming Early for Palantir Investors